To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
The Seoul-based private equity and secondaries fund manager has exited its investment in Medy-Tox, generating a net IRR of 33.2% in two years.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Copyright PEI Media
Not for publication, email or dissemination